FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896632059> ?p ?o ?g. }

• W2896632059 endingPage "e687" @default.
• W2896632059 startingPage "e686" @default.
• W2896632059 abstract "Locally-advanced non-small cell lung cancer (LA-NSCLC) patients are treated with chemoradiotherapy (CRT); however, approximately 15-20% of these patients develop significant morbidity with radiation pneumonitis (RP). Proton beam therapy (PBT) may reduce this risk. Currently, the most acceptable dosimetric predictors assume homogenous underlying lung function. We hypothesize that the risk of RP is correlated with dose to more highly ventilated portions of the lung, and PBT could be used to protect these areas of higher function. This study correlates the radiation dose in the low and high ventilation portions of the lung with RP outcome for patients treated with proton radiotherapy. This was a case-control retrospective study. 30 patients with LA-NSCLC treated between 2011 and 2016 with CRT were retrospectively identified, of whom 15 exhibited RP (graded using CTCAE v4.0) after PBT, and 15 were negative controls (matched based on age, smoking , tumor location and total dose). None received prior lung radiation and all satisfied institutional dosimetric constraints (V5<60%, V20Gy <37%, Mean lung dose < 20 Gy ). The inhale and exhale simulation CT scans were deformed using clinically validated deformable registration Advanced Normalization Tools . The 3D lung ventilation maps were derived from the deformation matrix and partitioned into low, medium and high ventilation zones for dosimetric analysis. A two-tailed student’s t test was used to correlate dose in each ventilation zone with risk of RP. The typical dose parameters V5 (37.2 ± 6.1 Gy vs 32.6 ± 7.3 Gy) and V20 (30.4 ± 5.7 Gy vs 27.2 ± 5.4 Gy) were higher for pneumonitis patients, though not statistically significant (p = 0.073, 0.127, respectively). In the low ventilation portion of the lung, similar dose distribution was observed for V20 between the RP (9.6± 2.7 %) and non-RP (9.7± 2.3 %) groups (p=0.914). V5 was also not significantly different (11.9±2.8 % vs 12.1± 2.7 %, p = 0.856). However, in the high-ventilation portions of the lung, RP group had higher V5 (12.5 ± 2.4 % vs. 9.3 ± 4.0 %, p = 0.012) and V20 (10.1 ± 2.4 % vs. 7.3 ± 3.6 %, p = 0.018). Furthermore, the mean dose in the high-ventilation portions of the lung of the RP patients was significantly higher than that of the non-RP patients (16.8 ± 4.4 Gy vs. 11.7 ± 6.1 Gy, p=0.015), while the mean dose in the low-ventilation portion of the lung did not show such differentiation (16.3 ± 5.0 Gy vs. 15.6 ± 4.2 Gy, p = 0.683). There is accruing data demonstrating that radiation dose to the functional high ventilated lung might serve as a predictor of RP. Our data supports these findings and is additionally the first study to demonstrate this in a cohort of patients treated with PBT. This is particularly promising given the greater ability to control dose to low versus high-ventilated portions of the lung using PBT compared to photon based RT . Further work will be needed to validate these findings in a larger cohort and compare these results in patients treated with photons." @default.
• W2896632059 created "2018-10-26" @default.
• W2896632059 creator A5008771585 @default.
• W2896632059 creator A5025660683 @default.
• W2896632059 creator A5030715490 @default.
• W2896632059 creator A5034399370 @default.
• W2896632059 creator A5035208282 @default.
• W2896632059 creator A5048669047 @default.
• W2896632059 creator A5070323665 @default.
• W2896632059 creator A5079349245 @default.
• W2896632059 creator A5079985074 @default.
• W2896632059 creator A5082385497 @default.
• W2896632059 creator A5088502637 @default.
• W2896632059 creator A5090002307 @default.
• W2896632059 date "2018-11-01" @default.
• W2896632059 modified "2023-09-24" @default.
• W2896632059 title "Avoiding Highly Functional Ventilation Zones as Defined by 4D Simulation Decreases the Risk of Radiation Pneumonitis During Proton Radiation Therapy for Lung Cancer" @default.
• W2896632059 doi "https://doi.org/10.1016/j.ijrobp.2018.07.1851" @default.
• W2896632059 hasPublicationYear "2018" @default.
• W2896632059 type Work @default.
• W2896632059 sameAs 2896632059 @default.
• W2896632059 citedByCount "0" @default.
• W2896632059 crossrefType "journal-article" @default.
• W2896632059 hasAuthorship W2896632059A5008771585 @default.
• W2896632059 hasAuthorship W2896632059A5025660683 @default.
• W2896632059 hasAuthorship W2896632059A5030715490 @default.
• W2896632059 hasAuthorship W2896632059A5034399370 @default.
• W2896632059 hasAuthorship W2896632059A5035208282 @default.
• W2896632059 hasAuthorship W2896632059A5048669047 @default.
• W2896632059 hasAuthorship W2896632059A5070323665 @default.
• W2896632059 hasAuthorship W2896632059A5079349245 @default.
• W2896632059 hasAuthorship W2896632059A5079985074 @default.
• W2896632059 hasAuthorship W2896632059A5082385497 @default.
• W2896632059 hasAuthorship W2896632059A5088502637 @default.
• W2896632059 hasAuthorship W2896632059A5090002307 @default.
• W2896632059 hasBestOaLocation W28966320591 @default.
• W2896632059 hasConcept C126322002 @default.
• W2896632059 hasConcept C126838900 @default.
• W2896632059 hasConcept C141071460 @default.
• W2896632059 hasConcept C143998085 @default.
• W2896632059 hasConcept C167135981 @default.
• W2896632059 hasConcept C27101514 @default.
• W2896632059 hasConcept C2776256026 @default.
• W2896632059 hasConcept C2777714996 @default.
• W2896632059 hasConcept C2778424827 @default.
• W2896632059 hasConcept C2779244869 @default.
• W2896632059 hasConcept C2779524853 @default.
• W2896632059 hasConcept C2989005 @default.
• W2896632059 hasConcept C509974204 @default.
• W2896632059 hasConcept C71924100 @default.
• W2896632059 hasConceptScore W2896632059C126322002 @default.
• W2896632059 hasConceptScore W2896632059C126838900 @default.
• W2896632059 hasConceptScore W2896632059C141071460 @default.
• W2896632059 hasConceptScore W2896632059C143998085 @default.
• W2896632059 hasConceptScore W2896632059C167135981 @default.
• W2896632059 hasConceptScore W2896632059C27101514 @default.
• W2896632059 hasConceptScore W2896632059C2776256026 @default.
• W2896632059 hasConceptScore W2896632059C2777714996 @default.
• W2896632059 hasConceptScore W2896632059C2778424827 @default.
• W2896632059 hasConceptScore W2896632059C2779244869 @default.
• W2896632059 hasConceptScore W2896632059C2779524853 @default.
• W2896632059 hasConceptScore W2896632059C2989005 @default.
• W2896632059 hasConceptScore W2896632059C509974204 @default.
• W2896632059 hasConceptScore W2896632059C71924100 @default.
• W2896632059 hasIssue "3" @default.
• W2896632059 hasLocation W28966320591 @default.
• W2896632059 hasOpenAccess W2896632059 @default.
• W2896632059 hasPrimaryLocation W28966320591 @default.
• W2896632059 hasRelatedWork W114545845 @default.
• W2896632059 hasRelatedWork W1866250621 @default.
• W2896632059 hasRelatedWork W2147178255 @default.
• W2896632059 hasRelatedWork W2366314651 @default.
• W2896632059 hasRelatedWork W2593609959 @default.
• W2896632059 hasRelatedWork W2973118855 @default.
• W2896632059 hasRelatedWork W4206726400 @default.
• W2896632059 hasRelatedWork W4324087809 @default.
• W2896632059 hasRelatedWork W4362735203 @default.
• W2896632059 hasRelatedWork W935391112 @default.
• W2896632059 hasVolume "102" @default.
• W2896632059 isParatext "false" @default.
• W2896632059 isRetracted "false" @default.
• W2896632059 magId "2896632059" @default.
• W2896632059 workType "article" @default.